Officials are worried that the surging frequency and severity of RSV cases coupled with COVID and seasonal viruses will put a large burden on the nation’s...
The studies come as Pfizer and BioNTech claim that preliminary research shows a third shot of their COVID vaccine appears to provide sufficient protection against the...
The deal will allow the drug to be inexpensively made and sold in 95 lower-income countries that make up more than half the world’s population but...
The approval will allow at-risk Americans who received Pfizer and Moderna vaccines to get any booster six months after their initial series and all Johnson &...
The panel refused to recommend boosters for Americans whose jobs put them at risk of contracting the coronavirus, but the agency’s head rejected that decision. CDC...
Pfizer Says Kids’ Vaccine Works Pfizer announced Monday morning that its joint COVID-19 vaccine with BioNTech is safe and effective in kids ages 5 to 11....
While some studies show that the effectiveness of Pfizer and Moderna’s COVID vaccines decrease over time, other publications argue the decline is not substantial and a...
While the company said that simply giving a third shot of its original vaccine could offer more potent protection against the variant, it wants to begin...
FDA officials told reporters Monday that the agency will approve Pfizer’s coronavirus vaccine for children 12 to 15 years old by next week. Last month, Pfizer...
Less than 1 in 4 currently unvaccinated Americans are willing to take Johnson & Johnson’s single-shot COVID-19 vaccine, according to a Washington Post-ABC News poll. The...
